Editas Q3 Loss Narrower Than Expected at $23.4M vs $27.7M Estimate
EDIT sits 57% above its 52-week low of $1.66.
Summary
Editas posted a Q3 net loss of $23.393 million, better than the $27.7 million loss IBES analysts expected. Operating expenses came in at $34.647 million, and collaboration and other R&D revenue added $10.4 million. EPS was -$0.15. The beat is modest in absolute terms but meaningful for a company this size, where the loss came in roughly $4 million lighter than consensus. Cash burn remains the story: the company registered a $400M shelf and launched a $150M ATM with Leerink in late August, so the balance sheet and any change to runway guidance matter more than the quarterly loss line itself.
At the time of this announcement, EDIT was trading at $2.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $394.7M. The 52-week trading range was $1.66 to $3.94. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.